Board of Podiatric Medical Examiners
E-Prescribing Waiver Information and Application
T.C.A. 63-1-160 requires that on or after January 1, 2021, any prescription for a Schedule II, III, IV or V controlled substance issued by a prescriber who is authorized by law to prescribe the drug must be issued as an electronic prescription from the person issuing the prescription to a pharmacy.
A health care prescriber that is unable to comply with the electronic prescription requirement for a Schedule II, III, IV or V prior to January 1, 2021, may apply for a waiver from the requirement based on economic hardship or technological limitations that are not reasonably within the control of the health care prescriber or other exceptional circumstance demonstrated by the health care prescriber.
The granting of this application provides a waiver from the electronic prescription requirement and is effective from January 1, 2024 until December 31, 2024. There is no fee for this application. Health care prescribers will be notified via the email address provided by the health care prescriber of the Commissioner’s approval or denial of the waiver request. The application for waiver can be found at:
Please complete the electronic fillable form below and ensure your contact information and reason for requesting the waiver are filled in. Once you hit submit, you will receive an email asking you to verify your email address. Once you verify your email address you will receive a second email confirming receipt of your waiver.